Please carefully follow the guidelines below.

Any manuscripts not meeting these guidelines will be returned to the corresponding author for correction, which may cause significant delays in the peer review process.

The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (updated in December 2016 - http://www.icmje. org/icmje-recommendations.pdf). Authors are required to prepare manuscripts in accordance with CONSORT guidelines for randomized controlled clinical studies, STROBE guidelines for Observational original research studies, STARD guidelines for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE guidelines for experimental animal studies, TREND guidelines for non-randomized public behaviour and CARE checklist for case series.

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://dergipark.org.tr/tr/journal/3471/submission/step/manuscript/new. Manuscripts submitted via any other medium will not be evaluated.

Title, type of the manuscript, full names of the authors, their ORCID numbers and addresses at the time of the research was carried out should be submitted during on-line submission.

Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office will ensure that the manuscript is prepared and submitted in accordance with the journal’s guidelines. Submissions that don’t conform the journal’s guidelines will be returned to the submitting author with technical correction requests.

Authors are required to submit the documents below, during the initial submission. Required forms are available on the journal’s website.
1) Copyright Transfer Form,
2) Author Contributions Form,
3) Similarity report (The similarity rate should be less than %20),
4) Approval of Ethics Committee (if required),
5) ICMJE Potential Conflict of Interest Disclosure Form (should be filled in by all contributing authors)

Title page: A separate title page should be submitted with all submissions and this page should include;
The full title of the manuscript as well as a short title (running head) of no more than 50 characters, Name(s), affiliations of the author(s), Grant information and detailed information on the other sources of support, the Name, address, telephone (including the mobile phone number) and fax numbers and an e-mail address of the corresponding author, acknowledgement of the individuals who contributed to the preparation of the manuscript not fulfilling the authorship criteria.
The first letters of authors’ names should begin with capital letter, and surnames should be written with capital letters. If there is more than one author; corresponding author should be indicated. The name, surname, work address, telephone, fax and e-mail address of the corresponding author should be submitted at the related page. The e-mail address should be selected as the most permanent one.
The title of the article should be written in lower letters in the title page. Acknowledgement, author(s) contribution(s), funding, ethical approval should be indicated at the end of the title page as a separate subtitle. Writing information about ‘Author Contribution, Conflict of Interest, Funding and Ethical statement’ is obligatory.

Abstract: An abstract should be submitted with all submissions except for letters to the editor. The abstract of Original Articles should be structured with subheadings (Background and Purpose, Methods, Results and Conclusion). The abstract must not be longer than 200 words and must clearly emphasise the objective of the study, experimental procedure(s), key results, and conclusions. The abstract must not contain mathematical formulae and an abbreviation.  The abstract must not contain any reference citations.

Keywords: Each submission must be accompanied by a minimum of three and a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations.

Manuscript Types
1) Original Articles: This is the most important type of article since it provides new information based on original research. If the information is accurate and important, and the conclusions are substantiated by the data provided, the paper serves to advance health sciences.
The main text should be structured with Introduction, Materials and Methods, Results and Discussion subheadings.
Statistical analysis to support conclusions is usually necessary. Statistical analyses must be conducted in accordance with the international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and statistical software that was used during the process must certainly be specified. Data must be expressed as mean±standard deviation when parametric tests are used to compare continuous variables. Data must be expressed as median (minimum-maximum) and percentiles (25th and 75th percentiles) when non-parametric tests are used. In advanced and complicated statistical analyses, relative risk (RR), odds ratio (OR) and hazard ratio (HR) must be supported by confidence intervals (CI) and p values.

Description: Clinical trial, Meta-analysis, Interventional study, Cohort study, Epidemiologic assessment, Survey with high response rate, Cost-effectiveness analysis, Decision analysis, Study of screening and diagnostic tests, Observational study
Requirements: 3000 words, ≤5 tables and/or figures, Structured abstract, ≤50 references

2) Review Articles: Review articles are scientific analysis of recent developments on a specific topic as reported in the literature. Articles prepared by authors who have an extensive knowledge on a particular field and whose scientific background has been translated into high volume of publication and high citation potential are taken under review. No new information is described, and no opinions or personal experiences are expressed. Reviews should only include the highlights on a topic. The authors can structure the main text of review articles according to their preferences.

Description: Up-to-date review on a topic of general common interest from the perspective of internationally recognized experts in these disciplines. The focus should be an update on current understanding of the physiology of the disease or condition, diagnostic consideration, and treatment. These reviews should address a specific question or issue that is relevant for clinical practice.
Requirements: 2000-3500 words, ≤5 tables and/or figures, Unstructured abstract, ≤75 references

3) Case Report: These manuscripts are short reports of original studies or evaluations or unique, first-time reports of clinical case series.
Description: Short reports of original studies or evaluations or unique, first-time reports of clinical case series.
Requirements: 1000-1200 words (not including abstract, tables, figures, acknowledgments, references, and online-only material), ≤5 tables and/or figures, Structured abstract, ≤15 references

4) Letter to the Editor and Reply: Letters to the Editor and Replies should offer objective and constructive criticism of published content. Letters may also discuss matters of general interest to physicians and academicians and may include images.
Description: Letters discussing a recent article in this journal should be submitted within 4 weeks of the article's publication online.
Requirements: 400 words, ≤3 authors≤5 references (1 of which should be to the recent article)

Main text
Names of the authors and their affiliations should not be stated in the file containing main text. Text should be prepared with MS Word document. All text should be written with Arial font type at 10 font size and 1.15 spaced on A4 sized paper with 2.5 cm right margin and 2.5 cm other margins. There should be no indentation at the beginning of the paragraph. Header and/or footer should not be inserted in the text except that the pages should be numbered with Arabic numerals. Title should be written in sentence case; that is, first letter of the initial word should be written in capital letter and rest of the title should be typed with lower case letters except proper nouns and abbreviations.

Tables
Tables should be included in the main document, presented after the reference list and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title must be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide an easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text.

Figures and Figure Legends
Figures, graphics and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should not be labelled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures should be blind as well. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300 DPI. To prevent delays in the evaluation process all submitted figures should be clear in resolution and large in size (minimum dimensions 100x100 mm). Figure legends should be listed at the end of the main document.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and the main text. The abbreviation should be provided in parenthesis following the definition.

When a drug, product, hardware, or software mentioned within the main text product information, including the name of the product, producer of the product, city of the company and the country of the company should be provided in parenthesis in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)”
All references, tables and figures should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text.

Limitations, drawbacks and shortcomings of original articles should be mentioned in the “Discussion” section before the conclusion paragraph.

Gene Names, Symbols, and Accession Numbers
Authors describing genes or related structures in a manuscript should include the names and official symbols provided by the US National Center for Biotechnology Information (NCBI) or the HUGO Gene Nomenclature Committee.

References
While citing publications, preference should be given to the latest, most up to date publications. If an ahead of print publication is being cited the DOI number should be provided. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ Medline/PubMed (for journal abbreviations consult the List of Journals indexed for MEDLINE, published annually by NLM). When there are 6 or fewer authors, all authors should be listed. If there are 7 or more authors the first 3 authors should be listed followed by “et al”. In the main text of the manuscript, references should be cited using Arabic numbers in parentheses. The reference styles for different types of publications are presented in the following examples:

Journal article: Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005;54(1):122-127.
Book Section: Sherry S. Detection of thrombi. In: Strauss HE, Pitt B, James AE, editors. Cardiovascular Medicine. St Louis: Mosby; 1974.p.273-285.
Books with Single Author: Cohn PF. Silent myocardial ischemia and infarction. 3rd ed. New York: Marcel Dekker; 1993.
Editor(s) as author: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.
Conference Proceedings: Bengisson S. Sothemin BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992.p.1561-1565.
Scientific or Technical Report: Smith P. Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX) Dept. of Health and Human Services (US). Office of Evaluation and Inspections: 1994 Oct. Report No: HHSIGOE 169200860.
Thesis: Kaplan SI. Post-hospital home health care: the elderly access and utilization (dissertation). St. Louis (MO): Washington Univ. 1995.
Epub ahead of print Articles: Aksu HU, Ertürk M, Gül M, Uslu N. Successful treatment of a patient with pulmonary embolism and biatrial thrombus. Anadolu Kardiyol Derg 2012 Dec 26. doi: 10.5152/akd.2013.062. [Epub ahead of print]
Manuscripts published in electronic format: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis (serial online) 1995 Jan-Mar (cited 1996 June 5): 1(1): (24 screens). Available from: URL: http:/ www.cdc.gov/ncidodlElD/cid.htm.

‘Manuscripts accepted for publication, not published yet’ cannot be cited as a reference.

REVISIONS
When submitting a revised version of a paper, the author must submit a detailed “Response to reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be cancelled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 30-day period is over.

PROOFS AND DOI NUMBER
Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed its PDF proof is prepared for the checks. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within 2 days of their receipt of the proof. Manuscripts accepted for publication are provided with a DOI number immediately after proof check.

*Please get in direct contact with the Editorial Office if you have any questions or comments regarding the peer-review process.

** JBACHS is published three times a year in January, May and September upon the request of Institute of Health Sciences.

Author Contribution: https://dergipark.org.tr/tr/journal/3471/file-manager/22630/download   
Conflict of Interest: https://dergipark.org.tr/tr/journal/3471/file-manager/22631/download 
Copyright Transfer Form: https://dergipark.org.tr/tr/journal/3471/file-manager/22632/download 
Main Text Template: https://dergipark.org.tr/en/download/journal-file/24590 
Title Page Template: https://dergipark.org.tr/en/download/journal-file/24591 
Case Report Template: https://dergipark.org.tr/en/download/journal-file/24662 

An approval of research protocols by Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects”, amended in October 2013, www.wma.net) is required for experimental, clinical and drug studies and some case reports. If required, ethics committee reports or an equivalent official document may be requested from the authors. For manuscripts concerning experimental research on humans, a statement should be included that shows informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly. Information on patient consent, name of the ethics committee and the ethics committee approval number should also be stated in the materials and methods section of the manuscript. It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, signed releases of the patient or of their legal representative should be enclosed.